Skip to main content

Table 2 Symptoms and exposure between cohorts

From: Post-infectious sequelae after Campylobacter enteric infection: a pilot study in Maricopa County, Arizona, USA

Symptoms and exposures

Eligible (not enrolled) N = 184

N (%)

Enrolled N = 102

N (%)

p value*

Diarrhea

177 (97.8)

100 (98.0)

0.89

 Bloody diarrhea

45 (24.5)

28 (27.5)

0.58

 Watery diarrhea

66 (35.9)

34 (33.3)

0.67

 Mucousy diarrhea

137 (74.5)

87 (85.3)

0.03

Fever

102 (61.8)

68 (73.9)

0.05

Nausea

102 (57.6)

62 (63.3)

0.36

Vomit

70 (38.9)

41 (41.4)

0.68

Abdominal pain

147 (80.33)

89 (89.0)

0.06

Headache

104 (57.5)

64 (64.7)

0.24

Other symptoms

79 (42.9)

62 (60.8)

0.004

 Chills

20 (7.0)

21 (20.6)

0.0001

Antibiotics in month prior

24 (13.6)

8 (7.8)

0.15

Antacids in month prior

70 (39.6)

38 (38.0)

0.80

Healthcare outcomes

  

0.68

 Primary care

79 (43.2)

49 (48.5)

 

 Hospitalization

60 (32.8)

28 (27.7)

 

 ED/urgent care only

43 (23.5)

24 (23.8)

 

Chronic condition

 None

99 (53.8)

41 (40.2)

0.03

 IBS

8 (4.4)

2 (2.0)

0.29

 Chronic gastritis

1 (0.5)

1 (1.0)

0.67

 Diabetes

20 (10.9)

13 (12.8)

0.63

 Arthritis

6 (3.3)

7 (6.9)

0.16

 Other

67 (36.4)

53 (51.9)

0.01

  Thyroid

2 (0.6)

6 (5.8)

0.02

  Hypertension

2 (0.6)

6 (5.8)

0.02

  1. *Chi-squared test comparing those eligible but not enrolled and enrolled, bolded variables indicate statistically significant differences between groups